Intrinsiqs

Is BioMarin Pharmaceutical Inc. overvalued?

BioMarin Pharmaceutical Inc. (BMRN) — key valuation metrics and fundamentals.

No verdict
Price
$58.09
Fair value
Current P/E
Normal P/E
Market cap
$11.37B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares BMRN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.